About
Heparin Derivatives
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule Pharmaceutical
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
224
By Phase
PHASE1: 1PHASE2: 1PHASE1/PHASE2: 1
By Status
COMPLETED: 2TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Today
Hover over trial bars to see details
Recent Trials
NCT03853421Lead Sponsor
Placebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of Sevuparin
PHASE1Completed
24 participants
Started: Feb 6, 2019 · Completed: May 6, 2019
NCT02515838Lead Sponsor
Sevuparin Infusion for the Management of Acute VOC in Subjects With SCD
PHASE2Completed
147 participants
Started: Jul 31, 2015 · Completed: May 31, 2019
NCT01442168Lead Sponsor
Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria
PHASE1/PHASE2Terminated
53 participants
Started: Sep 30, 2011 · Completed: Jan 31, 2014
Locations (1)
Headquarters
Stockholm, Sweden
Map
Loading map...